Transmissible Spongiform Encephalopathy
Transmissible spongiform encephalopathies are invariably fatal mammalian neurodegenerative disorders caused by nucleic-acid-free infectious prion proteins that template beta-sheet misfolding of host cellular prion protein, producing cortical vacuolation, astrogliosis, and neuronal loss.
Transmissible spongiform encephalopathy (TSE) designates a family of progressive, universally fatal neurodegenerative disorders affecting humans and non-human mammals that transmit horizontally or vertically without any viral, bacterial, fungal, or viroid nucleic-acid genome. Encompassing ovine scrapie, bovine spongiform encephalopathy (BSE), cervine chronic wasting disease (CWD), epidemic kuru, and Creutzfeldt–Jakob disease (CJD), TSEs are caused by infectious protein conformers termed prions, formulated in 1982 by American neurologist and biochemist Stanley B. Prusiner. Uniquely across medical nosology, TSEs arise through three distinct etiological pathways—idiopathic sporadic onset, autosomal-dominant germline inheritance, and acquired infectious transmission—all converging on autocatalytic conformational templating of a host-encoded membrane sialoglycoprotein.
Conformational Pathogenesis and Neuropathological Triad
Templated Conversion of Host PrPC to Amyloid PrPSc
All mammalian TSEs require endogenous expression of the single-exon host gene PRNP (on human chromosome 20p13); transgenic Prnp0/0 knockout mice are refractory to intracerebral prion inoculation. In healthy neural tissue, PRNP encodes a 208-residue mature glycoprotein (cellular prion protein, PrPC) anchored via glycosylphosphatidylinositol (GPI) to pre- and postsynaptic neuronal lipid rafts. Native PrPC adopts a monomeric globular fold rich in α-helices (~42% α-helical content, ~3% β-sheet), dissolves in non-ionic detergents, and is rapidly hydrolyzed by serine endopeptidases such as proteinase K (protease).
During TSE progression, exogenous or stochastically nucleated PrPSc oligomers bind host PrPC and template an aberrant protein folding transition into an insoluble, parallel in-register intermolecular β-sheet (~43% β-sheet) amyloid core. Although PrPC and PrPSc share an identical primary amino-acid sequence and covalent N-glycans, steric-zipper cross-β packing shields residues ~90–230 from limited proteinase K digestion, leaving the diagnostic 27–30 kDa protease-resistant core (PrP 27–30). Distinct three-dimensional β-arch polymorphs of PrPSc encipher heritable prion strains with characteristic incubation periods, regional lesion profiles, and interspecies transmission barriers.
Spongiform Change, Astrogliosis, and Immunological Silence
Microscopic neuropathology across cerebral neocortex, striatum, thalamus, and cerebellum exhibits a classic triad:
- Neuropil Vacuolation ("Spongiform Change"): Intracellular 2 to 50 μm microvacuoles distend dendritic spines and axons, imparting a perforated, sponge-like gray-matter architecture.
- Reactive Astrocytic Gliosis: Hypertrophy and proliferation of glial fibrillary acidic protein (GFAP)-positive astrocytes accompany progressive synaptic loss.
- Selective Neuron Dropout and Amyloid Plaques: Widespread neuronal loss occurs alongside variable extracellular PrPSc plaques—unicentric spike-balled kuru plaques in cerebellum, multicentric plaques in Gerstmann–Sträussler–Scheinker syndrome, and "florid" plaques (amyloid cores ringed by vacuoles) in variant CJD.
Because PrPSc shares the host's primary amino-acid sequence, adaptive B and T lymphocytes tolerate it as immunological "self": brain destruction unfolds without perivascular lymphocytic infiltrate, interferon response, or cerebrospinal fluid (CSF) pleocytosis.
Classification of Mammalian and Human TSEs
| TSE Disease Entity | Natural Host & Primary Etiology | Dominant Transmission or Mutation Mechanism | Characteristic Clinical & Diagnostic Features |
|---|---|---|---|
| Scrapie | Sheep & goats (recorded since 1732) | Horizontal placental/perinatal & pasture persistence | Intense pruritus, wool loss, cerebellar gait ataxia, death in 1–6 months |
| Bovine Spongiform Encephalopathy (BSE) | Cattle (>180,000 UK cases peaking 1992–1993) | Recycling prion-infected ruminant meat-and-bone meal (MBM) | Apprehension, hyperesthesia, hindlimb ataxia; controlled via ruminant feed bans |
| Chronic Wasting Disease (CWD) | Deer, elk, moose, reindeer (wildlife panzootic) | Saliva, urine, & feces shedding; clay-mineral soil binding | Emaciation, sialorrhea, polyuria; expanding across North America, Korea, & Fennoscandia |
| Sporadic CJD (sCJD) | Humans (~85% of human TSEs; ~1–2/million/yr) | Stochastic somatic PrPC misfolding; stratified by PRNP codon 129 & Type 1/2 PrPSc | Rapid dementia, startle myoclonus, ataxia, 1–2 Hz triphasic EEG waves, DWI cortical ribboning |
| Genetic / Familial TSEs | Humans (~10%–15%; autosomal dominant) | PRNP mutations: fCJD (E200K), GSS (P102L), Fatal Familial Insomnia (D178N-129M) | Multicentric cerebellar ataxia (GSS); untreatable thalamic agrypnia & dysautonomia (FFI) |
| Variant CJD (vCJD) | Humans (~233 global cases, median age ~28 yr) | Zoonotic dietary exposure to classic BSE beef products | Psychiatric/sensory prodrome, thalamic pulvinar sign on MRI, tonsillar lymphoreticular PrPSc |
| Kuru & Iatrogenic CJD (iCJD) | Humans (acquired infectious) | Mortuary endocannibalism (kuru); cadaveric hGH, dura mater grafts, depth electrodes (iCJD) | Prominent cerebellar truncal/limb tremor ("kuru"); incubation periods up to 40–50+ years |
Fore Kuru Epidemiology and PRNP Balancing Selection
Investigated in the 1950s by D. Carleton Gajdusek, Vincent Zigas, and Michael Alpers among the Fore people of Papua New Guinea, kuru ("trembling") killed up to 2% of villagers annually. Adult women and young children suffered an eight-to-ninefold higher incidence than men because women and children consumed prion-rich brain tissue at mortuary feasts while men ate skeletal muscle. Ending mortuary endocannibalism in the late 1950s halted juvenile cases while revealing incubation periods exceeding 50 years.
Genetic studies by Simon Mead and John Collinge demonstrated strong heterozygote advantage and balancing selection at polymorphic PRNP codon 129 (Methionine [M] / Valine [V]): because heterologous M and V monomers impede homotypic fibril elongation, elderly Fore feast survivors showed pronounced M129V enrichment alongside positive selection of a localized protective PRNP G127V allele.
Sterilization Physics and RT-QuIC CSF Diagnostics
Lacking nucleic acids, TSE agents withstand ionizing radiation, 254 nm UV photolysis, nucleases, boiling, ethanol, 10% neutral buffered formalin (which cross-links and stabilizes PrPSc infectivity inside paraffin blocks), and standard 121 °C steam autoclaving. Contaminated surgical instruments require single-use disposal or 1-hour immersion in 1 M NaOH or 20,000 ppm sodium hypochlorite followed by porous-load autoclaving at 134 °C for 18–60 minutes (and 95% formic acid treatment of fixed tissue blocks).
Antemortem diagnosis relies on Real-Time Quaking-Induced Conversion (RT-QuIC) of lumbar-puncture CSF or olfactory brushings: trace patient PrPSc seeds template recombinant PrPC conversion under intermittent shaking—multiplying fibril ends along N(t) = N0 exp(keff t)—detected via Thioflavin T fluorescence with 92%–97% sensitivity and >99% specificity for sporadic CJD.
Frequently Asked Questions
Why does chronic wasting disease spread horizontally among wild deer whereas sporadic CJD does not spread casually?
Whereas sporadic CJD prions remain confined largely to central nervous and retinal tissue, CWD prions replicate in deer pharyngeal lymphoid tissues, salivary glands, and gut/renal tracts, shedding into saliva, urine, and feces where PrPSc binds montmorillonite clay in soil and stays orally infectious for years.
How does one PRNP D178N mutation cause either Fatal Familial Insomnia or Familial CJD?
Phenotype depends on cis polymorphism at codon 129: D178N-129M produces a Type 2 PrPSc conformer targeting anterior/mediodorsal thalamus (Fatal Familial Insomnia), whereas D178N-129V produces a Type 1 conformer targeting cerebral cortex (familial CJD).
Can blood transfusions transmit human prion disease?
No transfusion transmission of sporadic CJD has been documented, but lymphotropic variant CJD caused four UK secondary cases via non-leukodepleted red-cell transfusions from preclinical donors, prompting universal leukoreduction.
References
- Prusiner, S. B. (1998). Prions. Proceedings of the National Academy of Sciences, 95(23), 13363–13383. https://doi.org/10.1073/pnas.95.23.13363
- Collinge, J. (Mar 2001). Prion diseases of humans and animals: their causes and molecular basis. Annual Review of Neuroscience, 24, 519–550. https://doi.org/10.1146/annurev.neuro.24.1.519
- Mead, S., Whitfield, J., Poulter, M., Shah, P., Uphill, J., Campbell, T., Al-Dujaily, H., Hummerich, H., Beck, J., Mein, C. A., Verzilli, C., Whittaker, J., Alpers, M. P., & Collinge, J. (Nov 19, 2009). A novel protective prion protein variant that colocalizes with kuru exposure. The New England Journal of Medicine, 361(21), 2056–2065. https://doi.org/10.1056/NEJMoa0809716
- Kraus, A., Groveman, B. R., & Caughey, B. (Sep 8, 2013). Prions and the potential transmissibility of protein misfolding diseases. Annual Review of Microbiology, 67, 543–564. https://doi.org/10.1146/annurev-micro-092412-155735